- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
HanAll Biopharma announced the appointment of Christopher Slavinsky as chief business development and legal officer.
Slavinsky joins HanAll from Coherus BioSciences, where he served as chief business and legal officer. Previously, he held leadership positions at Pharmacosmos Therapeutics, Prometheus Biosciences, Takeda, and Pfizer.
Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
President-elect Donald Trump announced he plans to appoint Cantor Fitzgerald President and CEO Howard Lutnick to lead the U.S. Commerce Department, as the incoming administration is expected to charge import tariffs against friends and foes.
A publicly traded cryptocurrency mining company will pay $10 million and completely change its business model to one with “lower corruption risk” as part of a settlement over violations of the Foreign Corrupt Practices Act (FCPA), two regulators announced.
Commercial real estate finance and advisory services firm Walker & Dunlop announced that Dan Groman will be its executive vice president, general counsel, secretary and chief compliance officer.
No comments yet